This inventor holds 1 USPTO granted patent. Top assignee: Almirall, S.a.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Isabelle Anne Lemasson
Introduction
Isabelle Anne Lemasson is a notable inventor based in Saffron Walden, Essex, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of sodium channel inhibitors. Her work is characterized by a commitment to advancing medical treatments through innovative chemical compounds.
Latest Patents
Isabelle holds one patent titled "Amino-substituted heterocyclic derivatives as sodium channel inhibitors." This invention relates to novel aminoindazolyl derivative compounds of Formula (I). The compounds are utilized in treating diseases mediated by the modulation of voltage-gated sodium channels, specifically Nav1.7. Additionally, the patent includes compositions containing these derivatives, showcasing her innovative approach to addressing medical challenges.
Career Highlights
Isabelle is currently employed at Almirall, S.A., where she continues to contribute to the field of pharmaceutical research and development. Her expertise in chemistry and pharmacology has positioned her as a valuable asset in her organization.
Collaborations
Isabelle has collaborated with notable colleagues, including James Duffy and Mark Stuart Chambers. These partnerships have likely enhanced her research efforts and contributed to the success of her projects.
Conclusion
Isabelle Anne Lemasson exemplifies the spirit of innovation in the pharmaceutical industry. Her work on sodium channel inhibitors demonstrates her dedication to improving medical treatments through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile